The overall goal of the UT Houston Substance Abuse Research-Medication Development Center (SARMDC) is to develop safe and effective medications for cocaine dependence through the study of the behavioral and neurochemical mechanisms associated with the promising initial findings of replacement therapy. The Administrative Core will promote this goal by serving as a general resource for other projects and the Advanced Clinical Design &Statistical Methodology Core.
The Specific Aims of the Administrative core are listed below:
Aim 1. To provide infrastructure support for clinical trials issues, including: a) subject recruitment and screening b) urine toxicology testing, c) ensuring subject confidentiality and compliance with IRB and HIPPA requirements and regulations d) documenting clinical trials on e) oversight of data sharing with NIDA.
Aim 2. To provide support for Training and Education, including recruitment, supervision, and evaluation of trainees affiliated with the center.
Aim 3. To provide Fiscal and Management support, including support for pilot studies, budgetary oversight, and management of research staff.
Aim 4. To serve as the Liaison between the center and outside entities including the Department of Psychiatry, the UT Health Sciences Center, the Center for Clinical Translational Science of the University of Texas Health Science Center at Houston, the scientific advisory board, collaborating entities including addiction researchers at Baylor College of Medicine and University of Texas Medical Branch (UTMB) in Galveston, as well as NIDA.

Public Health Relevance

The administrative core of the UT Houston Substance Abuse Research-Medication Development Center (SAR-MDC) will promote the goal of the center, to gain a greater understanding of the basic neurobiology of cocaine dependence in order to develop safe and effective treatments of the disorder, by providing infrastructure for clinical trials, training and education, and fiscal managerial support for the projects of the center

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Health Science Center Houston
United States
Zip Code
D'Souza MA, Johann M; Wardle PhD, Margaret; Green PhD, Charles E et al. (2018) Resting Heart Rate Variability: Exploring Associations With Symptom Severity in Adults With Substance Use Disorders and Posttraumatic Stress. J Dual Diagn :1-6
Vujanovic, Anka A; Wardle, Margaret C; Bakhshaie, Jafar et al. (2018) Distress tolerance: Associations with trauma and substance cue reactivity in low-income, inner-city adults with substance use disorders and posttraumatic stress. Psychol Addict Behav 32:264-276
Miller, William R; Fox, Robert G; Stutz, Sonja J et al. (2018) PPAR? agonism attenuates cocaine cue reactivity. Addict Biol 23:55-68
Vujanovic, Anka A; Smith, Lia J; Green, Charles E et al. (2018) Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial. Contemp Clin Trials 65:123-129
Ma, Liangsuo; Steinberg, Joel L; Wang, Qin et al. (2017) A preliminary longitudinal study of white matter alteration in cocaine use disorder subjects. Drug Alcohol Depend 173:39-46
Schmitz, Joy M; Green, Charles E; Hasan, Khader M et al. (2017) PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial. Addiction 112:1861-1868
Wardle, Margaret C; Vincent, Jessica N; Suchting, Robert et al. (2017) Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder. J Subst Abuse Treat 72:32-39
Ahn, Woo-Young; Ramesh, Divya; Moeller, Frederick Gerard et al. (2016) Utility of Machine-Learning Approaches to Identify Behavioral Markers for Substance Use Disorders: Impulsivity Dimensions as Predictors of Current Cocaine Dependence. Front Psychiatry 7:34
Azadeh, Shabnam; Hobbs, Brian P; Ma, Liangsuo et al. (2016) Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence. Neuroimage 125:813-824
Sharma, Jyoti; Rathnayaka, Nuvan; Green, Charles et al. (2016) Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding. Behav Med 42:1-8

Showing the most recent 10 out of 88 publications